✦ LIBER ✦

0131 Survival & safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment: A number needed to treat analysis based on the intergroup exemestane study (IES)

✍ Scribed by L.S. Kilburn; R. Mundayat; J.M. Bliss; C. Coombes; J. Chirgwin; C. Chen; L. Fallowfield; Z. Wang

Book ID: 114316269
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 52 KB
Volume: 18
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(09)70163-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival and safety of exemestane versus

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

✍ RC Coombes; LS Kilburn; CF Snowdon; R Paridaens; RE Coleman; SE Jones; J Jassem; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 314 KB

Survival and safety of exemestane versus

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

✍ RC Coombes; LS Kilburn; CF Snowdon; R Paridaens; RE Coleman; SE Jones; J Jassem; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 314 KB

## Background: Early improvements in disease-free survival have been noted when an aromatase inhibitor is given either instead of or sequentially after tamoxifen in postmenopausal women with oestrogen-receptor-positive early breast cancer. however, little information exists on the long-term effects

Carpal tunnel syndrome and musculoskelet

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

✍ J Sven D Mieog; James P Morden; Judith M Bliss; R Charles Coombes; Cornelis JH v 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 278 KB